What this study adds?
► Research in congenital heart disease remainsmale dominated. ► Manuscripts with a female first or senior authorand manuscripts with mixed gender authorship had higher impact factors and morecitations. ► Gender disparities are especially pronounced incertain geographic areas and this requires particular attention.
How might this impact on clinical practice?
► As it is unlikely that the problem will beself-rectifying, these data should inform policy recommendations to redressgender disparities.
AbstrAct
Background Women are underrepresented in leading medical positions and academia. The gender-gap in authorship of congenital heart disease (CHD) publications remains unknown. As determinants of gender equity in this field are poorly characterised, we aimed to quantify and characterise publications in CHD and to assess factors associated with female representation in research.
Methods and results
We identified 35 118 CHD publications between 2006 and 2015 for which author gender could be ascertained. Overall, 25.0% of all authors were female. Women accounted for 30.2% and 20.8% of all first and senior authorship positions with great geographic heterogeneity. While globally female first and senior authorship increased by 0.8% and 0.6%/year, some geographic regions showed no improvement in gender representation. Significant predictors of female first authorship on logistic regression analysis were country gross domestic product, human development index, gender inequality index and a female senior author (p<0.0001 for all). Publications with a female lead author tended to be published in journals with a higher impact factor (IF) and to attract more citations compared with those with a male author. Mixed gender authorship was associated with higher IF and number of citations. Women were less disadvantaged when the analysis was confined to original research. Conclusions While modest improvement in female authorship over time was noted, women remain underrepresented in contemporary academic CHD. Manuscripts with mixed gender authorship had higher IF and more citations. The main predictor of female first authorship was a female senior author. These data should inform policy recommendations regarding gender parity.
IntroduCtIon
A recognised imbalance exists in the participation of women in science and research globally. 1 Women continue to be underrepresented in published research in various academic fields. Using academic productivity as a metric, gender-gaps in authorship have been reported across the spectrum of medical disciplines. [2] [3] [4] [5] [6] [7] [8] Publishing in peer review journals continues to be an integral part of the promotion system and is generally regarded to be essential for rising to the top tiers of academic medicine. 4 A recent publication, for example, highlighted that women cardiologists were less likely than men to be full professors at US institutions even after accounting for factors associated with academic rank. 9 Congenital heart disease (CHD) represents a relatively young field in cardiology and is an emerging area in cardiovascular science. Due to its dynamic nature and fast growth-with an estimated increase in the number of adults with CHD by 60% per decade 10 -it could be argued that this pioneering area is in constant need of gifted, enthusiastic colleagues and that entrenched barriers to academic career entry and progression for women would limit the pool of talent available and hence be undesirable. As specific data on gender imbalance in research performance in the field of CHD are currently lacking, the aims of our report were: (1) to provide an overview over the magnitude of the 'gender gap' in CHD; (2) to assess temporal and geographical differences in female contribution to CHD research and (3) to provide insights into potential predictors of female authorship that in turn may inform future policy recommendations.
MetHods
The analysis included publications indexed in PubMed, focusing on CHD published over a 10-year period between 2006 and 2015. Publications of interest were initially electronically identified by using the major PubMed-MeSH term 'Heart Defects, Congenital'. Electronic queries were performed using R software (V.3.3.0, R Foundation for Statistical Computing) and the R-package RISmed. All retrieved articles underwent electronic filtering according to a prespecified protocol using both information available as part of the PubMed search and automatic text filtering of the manuscript title and abstract. Information on the search and categorisation strings used is presented in the online appendix of the manuscript. We excluded veterinary medicine publications and those focusing on electrical abnormalities of the heart in the absence of structural heart disease (eg, long-QT syndrome). The gender of the authors was analysed based on an established database linking authors' forenames to their respective gender, while accounting for country of origin (Gender API; gender-api. com). The database currently includes >1.8 million names from 178 countries. Articles with unavailable first names (eg, those providing only initials) and articles for which the first name could not be linked to author gender were excluded from the analysis. Publications were linked to the country of origin using the affiliation of the corresponding author or in case this was unavailable the affiliation of the first author.
To assess the relative quality of publications, impact factor (IF) data was retrieved for each paper based on the journal of origin and the year of publication. Journals without IFs for a given year were given an IF of zero but were counted as numbers of publications. To provide further information on the potential impact of individual publications, the number of citations a particular article attracted was also retrieved from the Thomson Reuters database and is provided. Data on the gross domestic product (GDP); the number of the practicing physicians and the national human development index (HDI) were obtained from the World Bank database (http://www. worldbank. org). In addition, information on the gender inequality index (GII) was retrieved from the United Nations Human Development Report. For all indices the 2010 data-representing the midpoint of our study period-was employed. To assess predictors of female participation in research, logistic regression analysis was performed. To this end, female first authorship was used as a dependent variable. Independent variables were first tested on univariable analysis and significant parameters were subsequently included in a multivariable stepwise analysis. For continuous dependent variables, we employed non-parametric regression (providing Spearman's rank correlation coefficient) as well as univariable and multivariable leastsquares regression analysis after log-transformation to achieve normal distribution. To assess the adequateness of the automatic classification by area of research, 250 randomly selected publications were selected and these underwent manual classification. The agreement between the two methods was evaluated using an interrater agreement (Kappa) test and the K-value is reported. For all analyses, a two-sided p<0.05 was considered significant.
results
The initial PubMed query identified 42 107 publications related to CHD published over a 10-year period between 2006 and 2015. After exclusion of papers focusing on veterinary medicine or congenital arrhythmia (without structural heart disease) as well as exclusion of publications for which author gender could not be ascertained, 35 118 papers remained and were included in the analysis (figure 1). Table 1 provides an overview over journal and In addition, cumulative publication numbers and impact factors of the top 10 countries contributing to research in the field of congenital heart disease are provided.
publication metrics as well as major countries contributing to published CHD research over the study period. In addition, it shows the percentage of female contributors in terms of overall, first and senior authorship. Women accounted for 25.0% of overall authorship positions, while contributing to 30.2% and 20.8% of all first and senior authorship positions, respectively ( 
Female contribution by geographic area
The percentage of publications authored by women differed between geographic regions and countries. 
Predictors of female authorship
On univariable logistic regression analysis, GDP, HDI, GII, number of physicians/capita and a female senior author of the publication correlated with the probability of the first author being female ( Congenital heart disease Table 5 shows the results of the univariable and multivariable parametric regression analysis after log-transformation of the number of female authors to account for non-normal distribution. The results illustrated in table 5 confirm the significant associations obtained from the non-parametric regression analysis while also providing multivariable adjustment. Gender distribution by type of publication and focus of research and gender disparities in original research publications are described in detail in the online supplement of the manuscript.
dIsCussIon
The current study highlights the contemporary academic gender gap in the field of CHD. It illustrates that even in this relatively young and dynamic area of cardiology, women remain underrepresented compared with men in terms of publication output. Evidence that this is not a lack of ability is inherent in the trend for manuscripts with a female lead author to be published in journals with a higher IF and to attract more citations compared with those with a male lead author, that mixed gender authorship was associated with higher IF and number of citations and that there is less disparity when analysis is confined to original research. Gender disparities are more pronounced in certain geographic areas and even within seemingly homogenous regions (such as Europe) large differences continue to persist. Interestingly, the strongest predictor of female first authorship was found to be a female academic in senior (last) authorship position. This finding may have policy implications, for example measures that enable establishment of a cadre of senior female leaders could result in female role models that subsequently act as catalysts for developing future junior female CHD researchers. While GDP-as a surrogate parameter for wealth and general level of economic development-was also positively correlated with equity in the field, it explains only a small fraction of the variability in the studied parameters of female involvement. In addition, some of the world's most wealthy countries, for example, Japan and Germany rank at the worst end of the spectrum in terms of female authorship participation. A notable exception are Eastern European countries exhibiting the highest proportion of female authors, approaching parity in terms of both first and senior authorship positions in some countries. However, Eastern Europe as a region is losing this relative advantage as we found a decrease in female academic output over the study period. This is in clear contrast to the general global trend of increased female contribution. Failing to foster available human capital and expertise in Europe and in many of its subregions could result in loss of competitiveness, for example, with respect to North America (see figure 5) .
The reasons for the underrepresentation of women in academic medicine have been discussed in detail by various previous reports. Potential factors include cultural gender bias, traditional societal gender roles, harassment and sexism in the work environment, lack of adequate mentorship or inaccessible modes of mentorship/ networking, domestic responsibilities disproportionately affecting women and institutional settings unwelcoming to part time or flexible working professionals. 11 12 Women may be subject to constrained rather than free choices as a result of these potential factors, which means they do not favour academic CHD. Subjecting women to gender microaggression may negatively affect their performance and reduce motivation. 13 14 Furthermore, women physicians have been found to be disadvantaged in terms of grant funding available. Previous US data suggest that female applicants receive smaller grants compared with male applicants 15 and this may negatively affect future professional opportunities for women in academic medicine. These factors, in combination, result in barriers even in geographic settings with a high proportion of female physicians and low overall gender inequality. Scandinavian studies suggest that despite favourable general cultural norms and equal opportunities laws, women are much less likely to achieve medical leadership positions or participate in decision making regarding academic research. 16 Beyond these general challenges, women in specific geographic settings are subject to worse discrimination due to outdated cultural norms or expectations and disproportionate burden of motherhood. 12 These factors have been cited to explain why women tend to be less likely to choose procedure-orientated medical subspecialties compared with their male peers. 17 Within Europe, Eastern Europe emerged as a relatively equitable subregion in the current study. This is probably due to historic reasons, including the feminisation of medicine in the former Soviet Union and countries within its sphere of influence. 12 18 It has been reported that women comprised approximately 70% of the physician workforce in the Soviet Union during the communist era. 18 However-as a caveat-some have also highlighted the relatively low social status of the medical profession as a whole and the fact that most women occupied rank-andfile positions, with the dominant figures continuing to be male in this pre-reform era. 12 18 Nonetheless, the current study highlights that academic CHD medicine continues to be more equitable in the East European regions, suggesting that women are not necessarily marginalised into providing routine clinical care but rather contribute significantly to academic research and knowledge gain in the field. Perhaps disturbingly, the relative contribution Congenital heart disease of women to academic CHD medicine in these regions is, however, now on the decline. We can only speculate about the reasons for this finding. Potential explanations include a 'brain drain' through an exodus of physicians to countries with better working conditions and more favourable remuneration structures, insufficient funds available for research or inadequate support for the field by leaders in cardiovascular medicine affecting the female workforce more than the male. Improving career trajectories of female and male colleagues may require a combination of several approaches including provision of adequate support, fair remuneration structures, removal of structural and cultural barriers that prevent entry or turn women away from academic CHD, and redressing hierarchical structures whereby all the top tier positions are occupied by men. 18 Appropriate positive measures may include mentorship/sponsorship programmes and adequately funded local professional development programmes to support women who do choose academic CHD. This may also be required to address underrepresentation of women in surgical and interventional cardiology (transcatheter or electrophysiological) which have growing importance for long-term CHD clinical care. Lower participation of women in these CHD invasive subspecialties may in turn result in reduced participation in related clinical research. Consistent with this is our finding that women are disproportionately more likely to publish research related to fetal medicine or pregnancy outcomes, rather than, for example, electrophysiology or interventional cardiology (figures 6 and 7). To avoid a 'glass ceiling' effect mediated by peer regulation, female role-models/sponsors are urgently required to support younger female colleagues and to provide them with the informal socialisation and support generally available to men. 18 In fact, this notion is supported by the current data, as we found that 50% of the first authors on papers senior authored by a female colleague were women. This is in contrast with the ratio of approx. ¼ for male senior authors.
In addition, department chairs should ensure that able juniors achieve milestones required for promotion and ultimately tenure positions regardless of whether they are female or male and must take care to avoid unconscious bias. Furthermore, a culture shift towards enabling balance of clinical and scientific responsibilities as well as family-friendly initiatives to enhance career for male or female parents should be advocated. 11 To this end, strategic planning and increased transparency within organisations appear beneficial and need to be addressed at system level. As highlighted by Gottlieb, the possibility of formal sponsorship arrangements rather than mere mentorship should also be explored. Sponsorship has been defined essentially as a mentor with 'significant organisational influence … willingness to advocate for protégées … competitive assignments (and) leadership opportunities'. 19 Overall, we contend that the results of the current study concur with previous findings supporting strategic investment in career development programme for women in the field of CHD. 20 21 Our results highlight the importance of diversity in research. Publications with a mixed gender authorship panel were published in journals with a significantly higher IF and attracted significantly more citation compared with those from a single sex authorship panel. This finding is consistent with previous data 19 and underlines the business case for promoting gender diversity and equity beyond mere fairness reasons. We also found no evidence of lower quality of research published by women (both in terms of the journal's IF and the number of citations). This is consistent with previous reports correlating clinical outcomes with physicians' gender. 22 limitations The gender of the authors was determined by automatic recognition and cross-checked with a large database of first names accounting for the country of origin of the author. While some names could not be linked to author gender, all major geographic regions relevant to the current study are well represented in the underlying database and it appears unlikely that systematic bias was introduced by the process. We cannot exclude the possibility that the higher average IFs achieved by females are-at least in part-due to a country effect, that is, more women authors are located in countries with generally higher IF counts. However, sensitivity analyses including only North America, Western and Northern Europe confirmed a slightly higher median IF for women first and last authors (2.618 vs 2.614; p=0.34 and 2.619 vs 2.606; p=0.19 for female first and senior authors, respectively). Despite being a recognised individual evaluation criterion in research, we did not include data on the H-Index in the current analysis. This is due the fact that this information was not available to us and because H-Index is a cumulative measure, whereas we were interested in temporal trends. Further studies are required to address this issue.
ConClusIon
Research in CHD remains male dominated, yet manuscripts with mixed gender authorship had higher IF and more citations. Gender disparities are especially pronounced in certain geographic areas and this requires particular attention. North and East European countries were found to be less inequitable than most other geographic settings though Eastern Europe is regressing on gender equity and thus in the process of losing its comparative advantage. The main drivers of gender equality were a senior female author and cultural factors. As it is unlikely that the problem will be self-rectifying, these data should inform policy recommendations to redress gender disparities.
